Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection.

Seib KL, Oriente F, Adu-Bobie J, Montanari P, Ferlicca F, Giuliani MM, Rappuoli R, Pizza M, Delany I.

Vaccine. 2010 Mar 11;28(12):2416-27. doi: 10.1016/j.vaccine.2009.12.082. Epub 2010 Jan 10.

PMID:
20067752
2.

Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitro.

Santos GF, Giuliani M, Santini L, Adu-Bobie J, Pizza M, Rappuoli R, Wacknov W, Donnelly J.

Clin Vaccine Immunol. 2009 Nov;16(11):1693-5. doi: 10.1128/CVI.00125-09. Epub 2009 Aug 26.

3.

Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.

Seib KL, Serruto D, Oriente F, Delany I, Adu-Bobie J, Veggi D, Aricò B, Rappuoli R, Pizza M.

Infect Immun. 2009 Jan;77(1):292-9. doi: 10.1128/IAI.01071-08. Epub 2008 Oct 13.

4.

A universal vaccine for serogroup B meningococcus.

Giuliani MM, Adu-Bobie J, Comanducci M, Aricò B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M.

Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10834-9. Epub 2006 Jul 6.

5.

Neisseria meningitidis NhhA is a multifunctional trimeric autotransporter adhesin.

Scarselli M, Serruto D, Montanari P, Capecchi B, Adu-Bobie J, Veggi D, Rappuoli R, Pizza M, Aricò B.

Mol Microbiol. 2006 Aug;61(3):631-44. Epub 2006 Jun 27.

6.

Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles.

Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, Biolchi A, Brunelli B, Giuliani MM, Pizza M, Norais N, Grandi G.

Proteomics. 2006 Mar;6(6):1856-66.

PMID:
16456881
7.

The impact of genomics on vaccine design.

Scarselli M, Giuliani MM, Adu-Bobie J, Pizza M, Rappuoli R.

Trends Biotechnol. 2005 Feb;23(2):84-91. Review.

PMID:
15661345
8.

Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells.

Capecchi B, Adu-Bobie J, Di Marcello F, Ciucchi L, Masignani V, Taddei A, Rappuoli R, Pizza M, Aricò B.

Mol Microbiol. 2005 Feb;55(3):687-98.

9.

Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.

Serruto D, Adu-Bobie J, Capecchi B, Rappuoli R, Pizza M, Masignani V.

J Biotechnol. 2004 Sep 30;113(1-3):15-32. Review.

PMID:
15380644
10.

GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence.

Adu-Bobie J, Lupetti P, Brunelli B, Granoff D, Norais N, Ferrari G, Grandi G, Rappuoli R, Pizza M.

Infect Immun. 2004 Apr;72(4):1914-9.

11.
12.

The genome revolution in vaccine research.

Capecchi B, Serruto D, Adu-Bobie J, Rappuoli R, Pizza M.

Curr Issues Mol Biol. 2004 Jan;6(1):17-27. Review.

13.

NarE: a novel ADP-ribosyltransferase from Neisseria meningitidis.

Masignani V, Balducci E, Di Marcello F, Savino S, Serruto D, Veggi D, Bambini S, Scarselli M, Aricò B, Comanducci M, Adu-Bobie J, Giuliani MM, Rappuoli R, Pizza M.

Mol Microbiol. 2003 Nov;50(3):1055-67.

14.

Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity.

Serruto D, Adu-Bobie J, Scarselli M, Veggi D, Pizza M, Rappuoli R, Aricò B.

Mol Microbiol. 2003 Apr;48(2):323-34.

15.

Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870.

Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, Brunelli B, Pieri A, Santini L, Savino S, Serruto D, Litt D, Kroll S, Welsch JA, Granoff DM, Rappuoli R, Pizza M.

J Exp Med. 2003 Mar 17;197(6):789-99.

16.

Two years into reverse vaccinology.

Adu-Bobie J, Capecchi B, Serruto D, Rappuoli R, Pizza M.

Vaccine. 2003 Jan 30;21(7-8):605-10.

PMID:
12531326
17.

NadA, a novel vaccine candidate of Neisseria meningitidis.

Comanducci M, Bambini S, Brunelli B, Adu-Bobie J, Aricò B, Capecchi B, Giuliani MM, Masignani V, Santini L, Savino S, Granoff DM, Caugant DA, Pizza M, Rappuoli R, Mora M.

J Exp Med. 2002 Jun 3;195(11):1445-54.

18.

A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis.

Granoff DM, Moe GR, Giuliani MM, Adu-Bobie J, Santini L, Brunelli B, Piccinetti F, Zuno-Mitchell P, Lee SS, Neri P, Bracci L, Lozzi L, Rappuoli R.

J Immunol. 2001 Dec 1;167(11):6487-96.

19.
20.

Human colostrum contains IgA antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins: intimin, BfpA, EspA, and EspB.

Loureiro I, Frankel G, Adu-Bobie J, Dougan G, Trabulsi LR, Carneiro-Sampaio MM.

J Pediatr Gastroenterol Nutr. 1998 Aug;27(2):166-71.

PMID:
9702647
21.

Detection of intimins alpha, beta, gamma, and delta, four intimin derivatives expressed by attaching and effacing microbial pathogens.

Adu-Bobie J, Frankel G, Bain C, Goncalves AG, Trabulsi LR, Douce G, Knutton S, Dougan G.

J Clin Microbiol. 1998 Mar;36(3):662-8.

22.

Down regulation of intimin expression during attaching and effacing enteropathogenic Escherichia coli adhesion.

Knutton S, Adu-Bobie J, Bain C, Phillips AD, Dougan G, Frankel G.

Infect Immun. 1997 May;65(5):1644-52.

23.

Molecular characterization of a carboxy-terminal eukaryotic-cell-binding domain of intimin from enteropathogenic Escherichia coli.

Frankel G, Candy DC, Fabiani E, Adu-Bobie J, Gil S, Novakova M, Phillips AD, Dougan G.

Infect Immun. 1995 Nov;63(11):4323-8.

Supplemental Content

Loading ...
Support Center